---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-073641"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:33:30.470377+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed raises ~$56M via public offering and private placement; grants warrant

## Summary
- Public offering of 9,413,637 shares at $2.75/sh + pre-funded warrants for 5,136,363 shares at $2.7499; gross $40M.
- Underwriters granted 30-day option for up to 2,182,500 additional shares at same price.
- Concurrent private placement: 5,895,608 shares to Ligand and Medtronic affiliate for ~$16.2M.
- Ligand receives warrant for up to 2M shares at $3.67, issued upon closing of placement.
- Proceeds to fund AVIM therapy BACKBEAT study, Virtue SAB program/trial, and general corporate.

## SEC filing metadata
- accession: 0001104659-25-073641
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465925073641/0001104659-25-073641-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465925073641/tm2522158d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-073641
- JSON: https://secwatch.observer/filing/0001104659-25-073641.json
- Plain text: https://secwatch.observer/filing/0001104659-25-073641.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.